Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model

Haematologica

Volumn 100, Issue 10, 2015, Pages e394-e397

  Stowell, Sean R ^a   Maridith Arthur, C ^a   Girard Pierce, Kathryn R ^a   Sullivan, Harold C ^a   Santhanakrishnan, Manjula ^b   Natarajan, Prabitha ^b   Patel, Seema R ^a   Tormey, Christopher A ^b,c   Zimring, James C ^d,e   Hendrickson, Jeanne E ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d Bloodworks Northwest Research Institute   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alloimmunization; RBC; Transfusion

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ANTISERUM; KEL PROTEIN, HUMAN; MEMBRANE PROTEIN; METALLOPROTEINASE;

ALLOIMMUNIZATION; ANTIGEN EXPRESSION; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION REACTION; HEMOLYTIC ANEMIA; HUMAN; LETTER; NONHUMAN; ADVERSE EFFECTS; ANEMIA, HEMOLYTIC; ANIMAL; DISEASE MODEL; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; IMMUNOLOGY; MOUSE;

ANEMIA, HEMOLYTIC; ANIMALS; DISEASE MODELS, ANIMAL; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; IMMUNE SERA; ISOANTIBODIES; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MICE;

EID: 84943232389     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.128603     Document Type: Letter

References (15)

1. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21(1):58-71.
2. Finn R, Clarke CA, Donohoe WT, et al. Experimental studies on the prevention of Rh haemolytic disease. Br Med J. 1961;1(5238):1486-1490.
3. Stowell SR, Girard-Pierce KR, Smith NH, et al. Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies. Transfusion. 2014;54(1):179-189.
4. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood. 2009;114(11):2315-2322.
5. Taylor RP, Lindorfer MA. Fcgamma-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments. Blood. 2015;125(5):762-766.
6. Zimring JC, Cadwell CM, Spitalnik SL. Antigen loss from antibodycoated red blood cells. Transfus Med Rev. 2009;23(3):189-204.
7. Williamson LM, Poole J, Redman C, et al. Transient loss of proteins carrying Kell and Lutheran red cell antigens during consecutive relapses of autoimmune thrombocytopenia. Br J Haematol. 1994; 87(4):805-812.
8. Bosco A, Xenocostas A, Kinney J, Cadwell CM, Zimring JC. An autoanti-Kp b immunoglobulin M that simulates antigen suppression. Transfusion. 2009;49(4):750-756.
9. Vengelen-Tyler V, Gonzalez B, Garratty G, et al. Acquired loss of red cell Kell antigens. Br J Haematol. 1987;65(2):231-234.
10. Stowell SR, Liepkalns JS, Hendrickson JE, et al. Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation. J Immunol. 2013;191(10):5013-5025.
11. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model. Transfusion. 2012;52(12): 2631-2645.
12. Yu H, Stowell SR, Bernardo L, et al. Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. J Immunol. 2014;193(6):2902-2910.
13. Diener E, Feldmann M. Antibody-mediated suppression of the immune response in vitro. II. A new approach to the phenomenon of immunological tolerance. J Exp Med. 1970;132(1):31-43.
14. Stucki M, Schnorf J, Hustinx H, et al. Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels. Transfus Clin Biol. 1998;5(3):180-188.
15. Beliard R, Waegemans T, Notelet D, et al. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies. Br J Haematol. 2008;141(1):109-119.